Profusa's stock dropped 3.77% after hours following a formal agreement to acquire G3 Vision Labs and subsidiaries, contingent on securing at least $30 million in financing, refinancing G3's debt, and obtaining shareholder approval for preferred stock conversion. The deal aims to create a public diagnostics company with national labs serving various healthcare sectors, backed by G3's projected $111 million revenue in 2025. Profusa must also maintain its Nasdaq listing before closing the transaction. The acquisition option remains open pending these conditions, with further details to be filed in Form 8-K.
AI/R, a technology company specializing in agentic AI, has joined Anthropic's Claude Partner Network Services Track. This partnership enhances AI/R's ability to develop AI solutions that improve operational efficiency and decision-making in complex b...
Affiliated Managers Group reported strong Q2 results with economic earnings per share of $8.29, beating estimates and marking a 58.3% increase year-over-year. Revenue rose nearly 30% to $640.7 million, driven by record Assets Under Management reachin...
The SPDR S&P 500 ETF Trust (SPY) experienced increased volatility at the end of July 2026 due to a sharp selloff in semiconductor stocks, which heavily impacted the technology sector and the broader S&P 500 index. This selloff contributed to the S&P ...
A prediction has been made that Tesla will lose its trillion-dollar market capitalization before the year 2027. This suggests a significant shift in investor confidence or market conditions affecting Tesla's valuation. The forecast highlights potenti...
Diebold Nixdorf's CFO Timko Thomas S purchased 700 shares at $72.29 following the company's strong Q2 2026 results. The company reported a 1.4% revenue increase to $928 million and an 8% rise in adjusted EBITDA to $121 million. Adjusted EPS surged 17...
